Ani Pharmaceuticals (ANIP) Enterprise Value (2010 - 2026)
Ani Pharmaceuticals' Enterprise Value came in at $1.61 billion for Q2 2026, up 30.3% from $1.24 billion a year earlier and up 6.5% from the prior quarter.
Ani Pharmaceuticals (ANIP) Enterprise Value (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ani Pharmaceuticals reported Enterprise Value of $754.97 million, down 5.5% year-over-year; for FY2025, it was $1.49 billion, up 45.8% from FY2024.
- Enterprise Value has increased in each of the last five years, with a five-year compound annual growth rate of 33.5% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $1.02 billion in FY2024 (+10.8%), $921.99 million in FY2023 (+40.6%), $655.8 million in FY2022 (+36.6%) and $480.12 million in FY2021 (+36.8%).
- The five-year range for quarterly Enterprise Value is $402.9 million (Q3 2021) to $1.85 billion (Q3 2025).
- Year-over-year, Enterprise Value has increased for 17 consecutive quarters, with growth averaging 24.1% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2023 (growth of 105.2%), and the weakest in Q1 2022 (a decline of 6.0%).
- Business Quant data shows ANIP's Enterprise Value at $1.52 billion (Q1 2026), $1.49 billion (Q4 2025) and $1.85 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Ani Pharmaceuticals | 1.78 Bn | 565.34 Mn | 165.89 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Bn |
| Mar 31, 2026 | 1.52 Bn |
| Dec 31, 2025 | 1.49 Bn |
| Sep 30, 2025 | 1.85 Bn |
| Jun 30, 2025 | 1.24 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.14 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 921.99 Mn |
| Sep 30, 2023 | 1.01 Bn |
| Jun 30, 2023 | 931.04 Mn |
| Mar 31, 2023 | 647.20 Mn |
| Dec 31, 2022 | 655.80 Mn |
| Sep 30, 2022 | 506.17 Mn |
| Jun 30, 2022 | 453.68 Mn |
| Mar 31, 2022 | 409.39 Mn |
| Dec 31, 2021 | 480.12 Mn |
| Sep 30, 2021 | 402.90 Mn |
Ani Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();